Lara Longpre Mirum Pharmaceuticals, Inc. (MIRM) insider trading activity

Lara Longpre is CHIEF DEVELOPMENT OFFICER of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 104,407 shares of MIRM, which is worth approximately $4.65 Million. The most recent transaction as insider was on Feb 02, 2024, when has been sold 847 shares (Common Stock) at a price of $26.19 per share, resulting in proceeds of $22,182. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K

0% 3M change

1.76% 12M change

Total Value Held $4.65 Million

Lara Longpre Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 02 2024	SELL Open market or private sale	$22,182 $26.19 p/Share	847 Reduced 0.8%	104,407 Common Stock
Jan 08 2024	SELL Open market or private sale	$28,572 $28.04 p/Share	1,019 Reduced 0.96%	105,254 Common Stock
Nov 10 2023	BUY Grant, award, or other acquisition	$9,673 $22.29 p/Share	434 Added 0.41%	106,273 Common Stock
Jul 03 2023	SELL Open market or private sale	$25,752 $25.65 p/Share	1,004 Reduced 0.94%	105,839 Common Stock
May 10 2023	BUY Grant, award, or other acquisition	$11,573 $16.92 p/Share	684 Added 0.64%	106,843 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	9,625 Added 8.31%	106,159 Common Stock
Jan 09 2023	SELL Open market or private sale	$20,681 $20.62 p/Share	1,003 Reduced 0.95%	104,369 Common Stock
Nov 10 2022	BUY Grant, award, or other acquisition	$1,398 $17.05 p/Share	82 Added 0.08%	96,534 Common Stock
May 10 2022	BUY Grant, award, or other acquisition	$19,731 $13.57 p/Share	1,454 Added 1.49%	96,452 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	10,000 Added 9.52%	94,998 Common Stock
Nov 10 2021	BUY Grant, award, or other acquisition	$10,181 $13.52 p/Share	753 Added 0.88%	84,998 Common Stock
Oct 01 2021	SELL Open market or private sale	$18,509 $19.26 p/Share	961 Reduced 1.13%	84,245 Common Stock
Sep 29 2021	BUY Grant, award, or other acquisition	-	8,125 Added 8.71%	85,206 Common Stock
May 10 2021	BUY Grant, award, or other acquisition	$18,407 $14.62 p/Share	1,259 Added 1.61%	77,081 Common Stock
Nov 10 2020	BUY Grant, award, or other acquisition	$12,552 $15.27 p/Share	822 Added 1.07%	75,822 Common Stock
Sep 10 2019	BUY Open market or private purchase	$10,267 $10.64 p/Share	965 Added 0.91%	105,372 Common Stock

Lara Longpre

CHIEF DEVELOPMENT OFFICER

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRM shares.

Notify only if

Value

Insider Trading

Get notified when an Mirum Pharmaceuticals, Inc. insider buys or sells MIRM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Mirum Pharmaceuticals, Inc.

Track Activities on MIRM

Account